Cargando…

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia

PURPOSE: We tested whether rosiglitazone (RGZ), a peroxisome proliferator-activated receptor-γ agonist, can restore alveolar development and vascular growth in a rat model of bronchopulmonary dysplasia (BPD). MATERIALS AND METHODS: A rat model of BPD was induced through intra-amniotic delivery of li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyun Ju, Lee, Youn Jin, Choi, Chang Won, Lee, Jin-A, Kim, Ee-Kyung, Kim, Han-Suk, Kim, Beyong Il, Choi, Jung-Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874901/ https://www.ncbi.nlm.nih.gov/pubmed/24339293 http://dx.doi.org/10.3349/ymj.2014.55.1.99

Ejemplares similares

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

Deferoxamine Improves Alveolar and Pulmonary Vascular Development by Upregulating Hypoxia-inducible Factor-1α in a Rat Model of Bronchopulmonary Dysplasia
por: Choi, Chang Won, et al.
Publicado: (2015)

Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats
por: Choi, Chang Won, et al.
Publicado: (2016)

Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Correction to: Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Interstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants
por: Kim, Hye-Rim, et al.
Publicado: (2017)

Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity
por: Kim, Hye-Rim, et al.
Publicado: (2021)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Recent Changes in the Incidence of Bronchopulmonary Dysplasia among Very-Low-Birth-Weight Infants in Korea
por: Jo, Heui Seung, et al.
Publicado: (2015)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
por: Kim, Sang Bum, et al.
Publicado: (2015)

Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study
por: Jung, Young Hwa, et al.
Publicado: (2019)

Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18–24 months of corrected age
por: Choi, Eui Kyung, et al.
Publicado: (2019)

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1
por: Hwang, Jung Seok, et al.
Publicado: (2012)

The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness
por: Keledjian, Kaspar, et al.
Publicado: (2020)

Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes
por: Hwang, Jae Kyoon, et al.
Publicado: (2023)

A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth
por: Heo, Ju Sun, et al.
Publicado: (2012)

Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats
por: Lee, Jin Woo, et al.
Publicado: (2010)

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
por: Jung, Jin Ah, et al.
Publicado: (2015)

The Association of Pregnancy-induced Hypertension with Bronchopulmonary Dysplasia – A Retrospective Study Based on the Korean Neonatal Network database
por: Shin, Seung Hyun, et al.
Publicado: (2020)

Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
por: Yang, Soo Jin, et al.
Publicado: (2011)

The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis
por: Ramakers, Julian D., et al.
Publicado: (2007)

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
por: Wang, Zhenyu, et al.
Publicado: (2020)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
por: Lecarpentier, Yves, et al.
Publicado: (2019)

Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue
por: Ryu, Seung Lok, et al.
Publicado: (2013)

Risk Factors for Late-onset Hyponatremia and Its Influence on Neonatal Outcomes in Preterm Infants
por: Kim, Yoon-Joo, et al.
Publicado: (2015)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Bronchoconstriction following instillation of phenylephrine eye drops in premature infants with bronchopulmonary dysplasia: two cases report
por: Kim, Hyun Jee, et al.
Publicado: (2015)

Risk Factors for Serious Bacterial Infection in Febrile Young Infants in a Community Referral Hospital
por: Shin, Seung Han, et al.
Publicado: (2009)

The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model
por: Guzeloglu, Mehmet, et al.
Publicado: (2012)

Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury
por: Bae, Seong Phil, et al.
Publicado: (2021)

Outcomes of infants with severe bronchopulmonary dysplasia in the pediatric intensive care unit
por: Choi, Yu Hyeon, et al.
Publicado: (2021)

Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia
por: Moreira, Alvaro, et al.
Publicado: (2019)

MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism
por: Kim, Seok-Ho, et al.
Publicado: (2019)

Effects of Postnatal Dexamethasone or Hydrocortisone in a Rat Model of Antenatal Lipopolysaccharide and Neonatal Hyperoxia Exposure
por: Lee, Hyun Ju, et al.
Publicado: (2012)

Neonatal Morbidities Associated with Histologic Chorioamnionitis Defined Based on the Site and Extent of Inflammation in Very Low Birth Weight Infants
por: Kim, Su Yeong, et al.
Publicado: (2015)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Chorioamnionitis: Is a major player in the development of bronchopulmonary dysplasia?
por: Choi, Chang Won
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_an782i3tgm03ir171o92lt9nq9